Finley John David: insider trades.
Finley John David reported 5 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 1 sale ($304K), across 1 company.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 1
- Companies
- 1
- Name as filed
- Finley John David
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Palisade Bio, Inc. (PALI) | Director, Officer · CEO, CFO | 5 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-19 | Palisade Bio, Inc. | G | 88,400 | $0 | 88,451 | Form 4 |
| 2026-08-19 | Palisade Bio, Inc. | G | 88,400 | $0 | 129,288 | Form 4 |
| 2026-07-07 | Palisade Bio, Inc. | M | 133 | $0.7 | 217,688 | Form 4 |
| 2026-07-07 | Palisade Bio, Inc. | S | 146,798 | $2.07 | 217,555 | Form 4 |
| 2026-07-06 | Palisade Bio, Inc. | M | 335,167 | — | 364,353 | Form 4 |
Questions
What stock did Finley John David buy or sell?
Finley John David reported 5 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 1 sale ($304K), across 1 company.
Is Finley John David the same person as other filers with this name?
This page covers SEC CIK 1851034 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/finley-john-david-1851034.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.